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Objectives: Traditionally, a gallbladder removed for presumed benign disease has been sent for histo-
pathological examination (HPE), but this practice has been the subject of controversy. This study was
undertaken to compare patients in whom gallbladder cancer (GBC) was diagnosed after cholecystectomy
on HPE with GBC patients in whom the gallbladder was not sent for HPE and who therefore presented
late with symptoms.
Methods: A retrospective analysis of prospectively collected data for 170 GBC patients diagnosed after
cholecystectomy was conducted. All patients presented to one centre during 2000–2011. These patients
were divided into two groups based on the availability of histopathology reports: Group A included
patients who presented early with HPE reports (n = 93), and Group B comprised patients who presented
late with symptoms and without HPE reports (n = 77).
Results: The median time to presentation in Group A was significantly lower than in Group B (29 days
vs. 152 days; P < 0.001). Signs or symptoms suggestive of recurrence (pain, jaundice or gastric outlet
obstruction) were present in four (4.3%) patients in Group A and all (100%) patients in Group B
(P < 0.001). Patients deemed operable on preoperative evaluation included all (100%) patients in Group
A and 38 (49.4%) patients in Group B (P < 0.0001). The overall resectability rate (69.9% vs. 7.8%) and
median survival (54 months vs. 10 months) were significantly higher in Group A compared with Group B
(P < 0.0001).
Conclusions: Patients in whom a cholecystectomy specimen was sent for HPE presented early, had a
better R0 resection rate and longer overall survival. Hence, routine HPE of all cholecystectomy specimens
should be performed.
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Introduction
Gallbladder cancer (GBC) is the most common cancer of the
biliary tract worldwide.1 Surgical resection of the tumour and its
loco-regional spread remains the only hope for longterm cure and
survival. Incidental GBC (IGBC) refers to GBC that is not sus-
pected before or at operation and even on gross examination of
the opened gallbladder specimen by the surgeon, but is detected
for the first time on histopathological examination (HPE) of a
gallbladder removed for presumed (clinical, ultrasound, opera-
tive) diagnosis of gallstone disease (GSD). In practical terms, all
GBCs not detected preoperatively and diagnosed during or fol-
lowing surgery are considered as IGBC. The incidence of IGBC
has been reported to range from 0.3–1.5% in various series.2
Although the overall prognosis of GBC is poor, IGBC is associated
with better outcomes.3,4 The literature-based support for a better
prognosis in IGBC is based on the fact that tumours detected on
HPE usually represent early-stage disease and patients are referred
DOI:10.1111/j.1477-2574.2012.00443.x HPB
HPB 2012, 14, 269–273 © 2012 International Hepato-Pancreato-Biliary Association
promptly by their treating physicians for definitive surgery.
Completion radical cholecystectomy is the standard treatment for
IGBC of stage Ib and beyond.3,5,6
The early-stage tumours for which surgical resection provides
the greatest benefit are difficult to diagnose preoperatively and are
often missed even after intraoperative examination of the chole-
cystectomy specimen.7–9 Hence, it has been standard practice to
submit all gallbladders removed for presumed GSD to routine
HPE to exclude gallbladder malignancy.10 In recent years, however,
the role of routine HPE of cholecystectomy specimens has been
questioned.11–15 In India, some centres do not send all cholecys-
tectomy specimens for HPE and this centre often manages post-
cholecystectomy GBC patients who present late in the course of
disease without HPE data and with symptoms of recurrence. This
provided an opportunity to study the impact of avoiding routine
histopathology of all cholecystectomy specimens.
This study was conducted to analyse the clinical presentation,
resectability rate and survival in patients with GBC diagnosed
after cholecystectomy based on HPE of the gallbladder and to
compare these data with equivalent data for GBC patients in
whom the gallbladder was not sent for HPE and who therefore
presented late with symptoms suggestive of recurrence.
Materials and methods
This study was a retrospective analysis of prospectively collected
GBC data for 170 patients with IGBC diagnosed after cholecys-
tectomy, who were referred to this centre during the period 2000–
2011.When HPE of the resected gallbladder had not been carried
out, the presence of a mass in the region of the gallbladder fossa
seen either on preoperative imaging or on exploratory laparotomy
was taken as corroborative evidence of GBC. Ultrasonography of
the abdomen was performed in all patients. Patients without evi-
dence of metastatic disease on ultrasound underwent contrast-
enhanced computed tomography (CT) of the abdomen to assess
resectability. Magnetic resonance imaging with cholangiography
and endoscopic retrograde cholangiography were carried out
selectively in patients with jaundice.
Patients who were considered unresectable on the basis of pre-
operative imaging were offered palliative non-surgical treatment;
a few patients, particularly in the earlier part of the study period,
underwent palliative surgery. Patients were treated based on their
tumour (T) stage: patients with T-stage Ib or higher and without
evidence of metastatic disease underwent a completion radical
cholecystectomy. If required, the bile duct, colon and any other
contiguous organs were resected en bloc to achieve a negative
margin (R0) resection. Patients with T-stage Ia disease underwent
regular follow-up.
Patients were divided into two groups: Group A comprised
patients who presented early with HPE reports, and Group B
consisted of patients who presented late with symptoms and
without HPE reports. Statistical analysis was performed using
GraphPad instat Version 4 (GraphPad Software, Inc., La Jolla,
CA, USA). Continuous variables were compared using the Mann–
Whitney test. Categorical variables were compared using Fisher’s
exact test and the chi-squared test. Survival probabilities were
estimated using the Kaplan–Meier method and compared using
the log-rank test. P-values of < 0.05 were considered to indicate
statistical significance.
Results
Of the 170 patients with GBC diagnosed after cholecystectomy, 93
were in Group A and 77 in Group B. Table 1 depicts the demo-
graphics and clinical features of patients in the two groups. Time
to presentation in Group A (median = 29 days, range: 1–70 days)
was significantly less than in Group B (median = 152 days, range:
38–1080 days) (P < 0.001). There were no significant differences
in age distribution or gender ratio between the two groups.
Abdominal pain as the presenting symptom was reported for 25
patients in Group B and four patients in Group A (P < 0.001).
None of the patients in Group A had jaundice or gastric outlet
obstruction (GOO), whereas 53 patients in Group B had jaundice
(n = 45) or GOO (n = 8) (P < 0.0001). Abdominal distension sec-
ondary to malignant ascites or intestinal (colonic) obstruction
was present in seven patients in Group B and no patients in Group
A (P = 0.003).
Table 2 depicts resectability and survival rates in the two
groups. On preoperative evaluation, all patients in Group A and
38 (49.4%) patients in Group B were found to be operable
(P < 0.0001). Of the 93 patients in Group A in whom surgery with
curative intent was performed, 65 underwent curative resection
(resectability rate: 69.9%). Of the 77 patients in Group B, 54 were
referred for surgery and 27 (35.1%) underwent surgery with cura-
tive intent because palliative segment III bypass was performed
frequently in patients with jaundice during the early part of the
study period. Only six of the 27 patients in Group B referred for
surgery with curative intent underwent curative resection (resec-
tability rate: 22.2%). Overall resectability was significantly higher
in Group A (69.9%, 65/93) than in Group B (7.8%, 6/77)
(P < 0.0001). Adjacent organ resection was performed in 13
Table 1 Patient demographics and clinical features in gallbladder
cancer patients presenting early with biopsy reports (Group A) or late
without biopsy reports (Group B)
Clinical parameter Group A
(n = 93)
Group B
(n = 77)
P-value
Time to presentation, days 29 (1–70) 152 (38–1080) < 0.001
Age, years, median (range) 51 (25–75) 53 (32–67) 0.983
Sex, male : female 1:4.5 1:3.5 0.571
Jaundice, n 0 45 <0.001
Gastric outlet obstruction, n 0 8 0.008
Abdominal pain, n 4 25 <0.001
Ascites/intestinal
obstruction, n
0 7 0.003
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patients in Group A and two patients in Group B (P = 0.591).
The median duration of follow-up was 36 months (range:
6–72 months) in Group A and 8 months (range: 3–22 months) in
Group B. Median survival was significantly higher in Group A
(54 months) than in Group B (10 months) (P < 0.001) (Fig. 1,
Table 3).
Discussion
Gallbladder cancer is the most common malignancy of the extra-
hepatic biliary tree.1 It is usually detected at an advanced stage and
is associated with a dismal prognosis.3 Although early-stage
tumours are associated with good prognosis, the preoperative
detection of tumours that are more likely to benefit from surgical
resection is difficult.7 The clinical presentation of early GBC is
non-specific and symptoms are similar to those of acute or chronic
cholecystitis. Although an expert radiologist can detect the
presence of early lesions in the form of focal gallbladder wall
thickening or lesions of small mass, not all cases of early GBC
present with an obvious lesion on abdomen ultrasonography.7
Someof the small lesionsmissedonpreoperativeultrasoundcanbe
picked up on gross examination of the cholecystectomy specimen.
Histopathological examination of the cholecystectomy specimen
facilitates the detection of tumours that are not apparent even on
gross examination of the specimen.8 Hence, it has been traditional
practice to send all cholecystectomy specimens for HPE.
Recently, however, various reports in the literature have
questioned the role of routine HPE in all cholecystectomy
specimens.11–15 The reasons given are that the incidence of IGBC
is too low to justify routine HPE, that routine HPE of all chole-
cystectomy specimens overburdens pathology and hospital
resources, that almost all cases of IGBC are associated with posi-
tive findings on gross examination of the gallbladder when it is cut
open and examined in the operating theatre, and that simple
cholecystectomy is adequate for early-stage tumours (carcinomas
in situ and T-stage Ia tumours).
The suggestion that routine HPE should be avoided is based on
the belief that examination of the cholecystectomy specimen in
the operating room reveals some suspicious findings in all cases of
IGBC. Some reports support this claim. Darmas et al. reported
IGBC in only four of 1452 (0.3%) patients for whom cholecystec-
tomy specimens were examined over a period of 5 years, all four of
whom demonstrated mass on gross examination of the cholecys-
tectomy specimen and two of whom showed preoperative suspi-
cions of malignancy.15 Bazoua et al. reported an analysis of HPE
reports for 2890 cholecystectomy specimens which showed malig-
nancy in 10 cases, all of which had demonstrated thick-walled
gallbladders on gross examination and in two of which suspicious
mass had been apparent.13 Recently, a centre in the south of India
reported its experience with 1312 cholecystectomy cases over a
10-year period.14 Of these, 610 (46.5%) cholecystectomy speci-
mens showed macroscopic abnormalities in the form of thicken-
ing, mucosal ulcerations or polypoidal lesions. Malignancy was
found in 13 of these 610 cholecystectomy specimens with macro-
scopic abnormalities. None of the cholecystectomy specimens
without macroscopic abnormalities were found to have GBC.14
Based on these findings, all these reports recommend the selective
HPE of cholecystectomy specimens with either preoperative or
intraoperative suspicious findings.
Table 2 Resectability rates and survival in gallbladder cancer patients presenting early with biopsy reports (Group A) or late without biopsy
reports (Group B)
Parameter Group A (n = 93) Group B (n = 77) P-value
Deemed unresectable on preoperative workup, n (%) 0 39 (50.7%) <0.001
Referred for surgery (curative intent), n (%) 93 (100%) 27 (35.1%) <0.001
Resectability in patients referred for surgery with curative intent, n (%) 65 (69.9%) 6 (22.2%) <0.001
Overall resectability, n (%) 65 (69.9%) 6 (7.8%) <0.001
Adjacent organ resection, n (%) 13 (14.0%) 2 (2.6%) 0.591
Median survival, months 54 10 <0.001
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Figure 1 Survival rates in Groups A and B
Table 3 Survival in gallbladder cancer patients presenting early with
biopsy reports (Group A) or late without biopsy reports (Group B)
Patients at risk, n Time in months
0 6 9 20 24 48 72
Group A 93 93 83 68 64 23 2
Group B 77 64 34 3 0 0 0
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Most of the GBC cases reported in these series showed suspi-
cions of malignancy on either preoperative evaluation or intraop-
erative examination of the cholecystectomy specimen. Incidental
GBC is, by definition, detected for the first time on HPE of gall-
bladders removed for presumed (clinical, imaging or operative
including the examination of the cut surface of the cholecystec-
tomy specimen) diagnosis of GSD. Several authors have reported
that preoperative imaging findings and intraoperative gross
examination may not be reliable in identifying malignancy.8,9 Roa
et al., in a report from Chile, observed that 37% of primary
tumours were macroscopically inapparent.8 Lohsiriwat et al.
reported the absence of pre- or intraoperative suspicion in all 24
cases of IGBC diagnosed on HPE of 4317 cholecystectomy speci-
mens examined over a period of 8 years.16 Recently, a report from
Nepal found that pre- and intraoperative examination was accu-
rate in identifying only 55% of all IGBC cases.9 All these reports
underscore the importance of routine HPE of all cholecystectomy
specimens.
In the present study, a retrospective analysis of 503 cholecystec-
tomy specimens removed from patients with presumed diagnoses
of GSD over a period of 2 years showed that 33 patients had
shown intraoperative suspicion of malignancy and the gallbladder
had been sent for frozen-section examination. Of these, only five
patients had evidence of malignancy. Of the remaining 470 speci-
mens in which there was no suspicion of malignancy on macro-
scopic examination of the cut-open cholecystectomy specimen,
GBC was diagnosed in four cases. Of these, one patient had stage
Ia disease, one had stage Ib disease and two had stage II disease.
Thus, it is evident that, despite careful macroscopic examination,
GBC can be missed and that implementing a policy of selective
HPE of cholecystectomy specimens will fail to identify tumours in
patients who might otherwise have a good prognosis.
Darmas et al. suggested that adopting amore selective approach
would reduce costs, resulting in an overall saving of GBP10 875 in
their series.15 They also suggested the histopathology workload
would be reduced by 3.5–4.0% per year if only selected cholecys-
tectomy specimens were examined. However, these benefits
should be weighed against the risk that early gallbladder malig-
nancies and potential chances to provide curative treatment in
this dismal disease might be lost. The projected cost-saving does
not look justifiable.
In patients with GBC, a radical R0 resection is the only hope for
cure. Patients with early-stage GBC benefit most from radical
resection. Although a proportion of IGBC patients with T-stage Ia
disease do not require further treatment (three patients in the
present series), a significant number of IGBC patients have stage
Ib or II disease and will benefit from radical resection.6 In the
present series, patients who were referred early by their treating
physicians (based on biopsy reports for gallbladders removed at
index surgery) had a 69.9% overall resectability rate. By contrast,
patients who presented late with symptoms (because HPE reports
were either not available or neglected) had a poor overall resect-
ability rate (7.8%). Time to presentation, which determined resec-
tability, was affected by the availability of an HPE report. Thus,
patients in whom evidence of malignancy was found on HPE of
the cholecystectomy specimen were referred early by their treating
physicians for completion radical cholecystectomy and had a
better rate of resectability.
In India, it is not uncommon for the removed gallbladder not to
be sent for HPE, especially in peripheral centres. As a result, many
patients present late at a time when their disease is usually
advanced or metastatic. The present series included a few patients
(nine patients in Group B) in whom a biopsy specimen had been
sent for HPE at the time of surgery, but the HPE report had not
been collected on follow-up by either the patient or the surgeon
until the patient had developed a recurrence. These patients also
presented late with signs and symptoms of advanced disease; their
outcomes were dismal and only on retrospective review of all
details was it found that the gallbladder specimen had been sent
for HPE. Based on this analysis, the present authors recommend
that all cholecystectomy specimens should be opened and exam-
ined. Any patient in whom findings on intraoperative exami-
nation are suspicious should benefit from frozen-section
examination of the cholecystectomy specimen. In all other
patients, the cholecystectomy specimen should be sent for routine
HPE so that the detection of early GBC is not missed in a sub-
group of patients who might derive maximum benefit from
radical resection.
Conclusions
Patients in whom a cholecystectomy specimen was sent for HPE
presented early and achieved a better R0 resection rate and better
overall survival, whereas those in whom the gallbladder was not
sent for HPE presented late with symptoms of recurrence, and had
a poor resectability rate and poor longterm survival. Hence, all
cholecystectomy specimens should be sent for histopathology.
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